Clinical trial Recruiting at 2 sites Interventional Ages 5 to 18

Pelvic floor training with or without dynamic neuromuscular stabilization for children with dysfunctional voiding

Official title: Effects of Adding Dynamic Neuromuscular Stabilization to Pelvic Floor Muscle Training on Voiding Dysfunction in Children: A Randomized Controlled Trial

Run by Necmettin Erbakan University · NCT07267364 · Data updated 2026-11-12

This will see if adding dynamic neuromuscular stabilization (spinal stabilization and muscle-synergy exercises) to standard pelvic floor muscle training helps children aged 5–18 with dysfunctional voiding improve symptoms and quality of life.

Quick facts

Study typeInterventional
Ages5 Years to 18 Years
SexAll
Enrollment48 (estimated)
SponsorNecmettin Erbakan University
Academic / other
Locations2 sites (Konya, Konya and 1 other locations)
StatusRecruiting
StartedNovember 11, 2025
Main results expectedFebruary 1, 2026
Study endsOctober 3, 2026
Registry record updatedOctober 6, 2026
Trial IDNCT07267364 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 5–18 diagnosed with dysfunctional voiding by ICCS criteria who can attend in-person sessions and whose parent/guardian can provide consent are the intended participants.

Probably not a fit

Children with organic urologic abnormalities (such as urethral obstruction, ectopic ureter, VUR), neurogenic bladder or spina bifida, diabetes, significant cognitive impairment, those under 5, or those already receiving PTC training or electrical stimulation are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Children diagnosed with dysfunctional voiding are randomized to pelvic floor muscle training (PFMT) alone or PFMT plus dynamic neuromuscular stabilization (DNS). PFMT is delivered three times weekly for 10 weeks and uses video instruction to teach pelvic floor awareness and contraction/relaxation techniques. DNS starts with spinal stabilization exercises and targets coordinated muscle synergies to support bladder control. Outcomes measured at baseline and after treatment include the Voiding Disorders Symptom Score (VODS) and the Pediatric Quality of Life Inventory (PedsQL 4.0).

Why it matters

Potential benefit: If successful, adding DNS to PFMT could reduce urinary symptoms and improve quality of life for affected children, potentially reducing the need for more invasive treatments.

How similar studies have gone: Pelvic floor muscle training is an established treatment for pediatric dysfunctional voiding, but combining PFMT with DNS is relatively novel and has limited prior pediatric evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Having been diagnosed with voiding dysfunction according to ICCS diagnostic criteria in a urology outpatient clinic,
* Being 5-18 years old,
* The child and their parent/guardian agree to participate in the study voluntarily and provide signed consent.

Exclusion Criteria:

* Organic pathologies such as urethral obstruction, ectopic ureter, spinal dysraphism, and diabetes
* Diagnosis of VUR or neurogenic bladder
* Cognitive and mental impairment
* Having spina bifida
* Being under 5 years of age
* Receiving treatment such as PTC training or electrical stimulation

Where it's running

  • Necmettin Erbakan University
    Konya, Konya, Turkey (Türkiye)
    Recruiting
  • Hanife Dogan
    Konya, Konya, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.